Total:625
S-1KK Combination Tablets T20(エスワンケーケー配合錠T20)
![]() |
|
It is usually used for treatment of gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, unresectable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1KK Combination Tablets T25(エスワンケーケー配合錠T25)
![]() |
|
It is usually used for treatment of gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, unresectable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1Meiji Combination Capsules T20(エスワンメイジ配合カプセルT20)
![]() |
|
It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer and biliary cancer. |
S-1Meiji Combination Capsules T25(エスワンメイジ配合カプセルT25)
![]() |
|
It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer and biliary cancer. |
S-1TAIHO combination OD tablets T20(エスワンタイホウ配合OD錠T20)
![]() |
|
It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
S-1TAIHO combination OD tablets T25(エスワンタイホウ配合OD錠T25)
![]() |
|
It is usually used to treat gastric cancer, colorectal cancer, head and neck cancer, non-small cell lung cancer, inoperable or recurrent breast cancer, pancreatic cancer, or biliary tract cancer. |
SAHNE Ointment 0.5%(ザーネ軟膏0.5%)
![]() |
|
It is usually used in the treatment of keratoderma. |
SALAGEN Granules 0.5%(サラジェン顆粒0.5%)
![]() |
|
It is usually used to improve dry mouth symptoms associated with radiation therapy to the head and neck and in patients with Sjogren's syndrome. |
SALAGEN Tab. 5mg(サラジェン錠5mg)
![]() |
|
It is usually used to improve dry mouth symptoms associated with radiation therapy to the head and neck and in patients with Sjogren's syndrome. |
SALAZAC COMBINATION GRANULES(サラザック配合顆粒)
![]() |
|
It is usually used to improve or relieve nasal discharge/congestion, pharyngeal and laryngeal pain, headache, joint pain, muscle pain and fever associated with common cold or upper respiratory tract inflammation. |
SALAZOSULFAPYRIDINE Enteric Coated Tablets 250mg "CH"(サラゾスルファピリジン腸溶錠250mg「CH」)
![]() |
|
It is usually used to treat rheumatoid arthritis. It may take 1 to 2 months for the medicine to be effective. |
SALAZOSULFAPYRIDINE Enteric Coated Tablets 500mg "CH"(サラゾスルファピリジン腸溶錠500mg「CH」)
![]() |
|
It is usually used to treat rheumatoid arthritis. It may take 1 to 2 months for the medicine to be effective. |
SALAZOSULFAPYRIDINE Tablet 500mg "Nichiiko"(サラゾスルファピリジン錠500mg「日医工」)
![]() |
|
It is usually used to treat ulcerative colitis, regional enteritis and nonspecific colitis. |
SALIPARA SOLUTION(サリパラ液)
![]() |
|
It is usually used to treat cough and difficulty in expectoration accompanied with acute bronchitis, pneumonia and pulmonary tuberculosis. |
SALOBEL Tablets100mg(サロベール錠100mg)
![]() |
|
It is usually used to treat gout or the symptom of hyperuricemia (in hypertension accompanied by hyperuricemia). |
SALOBEL Tablets50mg(サロベール錠50mg)
![]() |
|
It is usually used to treat gout or the symptom of hyperuricemia (in hypertension accompanied by hyperuricemia). |
SALSOROITIN Injection 10mL(ザルソロイチン静注10mL)
![]() |
|
It is usually used to treat symptomatic nerve pain and low back pain. |
SALSOROITIN Injection 20mL(ザルソロイチン静注20mL)
![]() |
|
It is usually used to treat symptomatic nerve pain and low back pain. |
SAMSCA Granules 1% [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカ顆粒1%[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Granules 1% [Volume overload in heart failure and body fluid retention in hepatic cirrhosis](サムスカ顆粒1%[心不全・肝硬変における体液貯留])
![]() |
|
It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD Tablets 15mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカOD錠15mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 15mg [Volume overload in heart failure](サムスカOD錠15mg[心不全における体液貯留])
![]() |
|
It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD Tablets 30mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカOD錠30mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 7.5mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカOD錠7.5mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA OD Tablets 7.5mg [Volume overload in heart failure and body fluid retention in hepatic cirrhosis](サムスカOD錠7.5mg[心不全・肝硬変における体液貯留])
![]() |
|
It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA OD tablets 15mg [Autosomal dominant polycystic kidney disease](サムスカOD錠15mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA OD tablets 30mg [Autosomal dominant polycystic kidney disease](サムスカOD錠30mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA OD tablets 7.5mg [Autosomal dominant polycystic kidney disease](サムスカOD錠7.5mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA Tablets 15mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカ錠15mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 15mg [Volume overload in heart failure](サムスカ錠15mg[心不全における体液貯留])
![]() |
|
It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA Tablets 30mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカ錠30mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 7.5mg [Hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH)](サムスカ錠7.5mg[抗利尿ホルモン不適合分泌症候群(SIADH)における低ナトリウム血症])
![]() |
|
It is usually used to treat hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
SAMSCA Tablets 7.5mg [Volume overload in heart failure and body fluid retention in hepatic cirrhosis](サムスカ錠7.5mg[心不全・肝硬変における体液貯留])
![]() |
|
It is usually used in combination with other diuretics when the other diuretics alone do not show sufficient effect. |
SAMSCA granules 1% [Autosomal dominant polycystic kidney disease](サムスカ顆粒1%[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 15mg [Autosomal dominant polycystic kidney disease](サムスカ錠15mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 30mg [Autosomal dominant polycystic kidney disease](サムスカ錠30mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMSCA tablets 7.5mg [Autosomal dominant polycystic kidney disease](サムスカ錠7.5mg[常染色体優性多発性のう胞腎])
![]() |
|
It is usually used to slow the progression of rapidly enlarging autosomal dominant polycystic kidney disease in which the kidneys have already become enlarged. |
SAMTIREL Oral Suspension 15%(サムチレール内用懸濁液15%)
![]() |
|
It is usually used to treat pneumocystis pneumonia and to suppress symptom onset. |
SANWA Kakkonkajutsubuto Extract Fine Granules(三和葛根加朮附湯エキス細粒)
![]() |
|
It is usually used to shoulder stiffness, nerve pain in the scapular region, and articular rheumatism in the upper body. |
SARCLISA I.V. Infusion 100mg(サークリサ点滴静注100mg)
![]() |
|
It is usually used to treat relapse/refractory multiple myeloma. |
SARCLISA I.V. Infusion 500mg(サークリサ点滴静注500mg)
![]() |
|
It is usually used to treat relapse/refractory multiple myeloma. |
SARPOGRELATE HYDROCHLORIDE Tablets 100mg [SANWA](サルポグレラート塩酸塩錠100mg「三和」)
![]() |
|
It is usually used for treatment of ischemic symptoms including ulcer, pain and chilly sensation, associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE Tablets 50mg [SANWA](サルポグレラート塩酸塩錠50mg「三和」)
![]() |
|
It is usually used for treatment of ischemic symptoms including ulcer, pain and chilly sensation, associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "NP"(サルポグレラート塩酸塩錠100mg「NP」)
![]() |
|
It is usually used to improve various ischemic symptoms such as ulcers/pain/cold feeling associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "OHARA"(サルポグレラート塩酸塩錠100mg「オーハラ」)
![]() |
|
It is usually used in the treatment of ulcer and improvement of the ischemic symptoms such as pain and coldness associated with chronic arterial obstruction. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "TOWA"(サルポグレラート塩酸塩錠100mg「トーワ」)
![]() |
|
It is usually used to treat various ischemic symptoms such as ulcer, pain and feeling of coldness associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 100mg "YD"(サルポグレラート塩酸塩錠100mg「YD」)
![]() |
|
It is usually used to treatment ulcer associated with chronic arterial occlusion and ischemic symptoms. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "NP"(サルポグレラート塩酸塩錠50mg「NP」)
![]() |
|
It is usually used to improve various ischemic symptoms such as ulcers/pain/cold feeling associated with chronic arterial occlusion. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "OHARA"(サルポグレラート塩酸塩錠50mg「オーハラ」)
![]() |
|
It is usually used in the treatment of ulcer and improvement of the ischemic symptoms such as pain and coldness associated with chronic arterial obstruction. |
SARPOGRELATE HYDROCHLORIDE TABLETS 50mg "TOWA"(サルポグレラート塩酸塩錠50mg「トーワ」)
![]() |
|
It is usually used to treat various ischemic symptoms such as ulcer, pain and feeling of coldness associated with chronic arterial occlusion. |